Expert Opinion on Emerging Drugs

Expert Opinion on Emerging Drugs
Abbreviated title (ISO 4)	EOMD
Discipline	peer-reviewed rapid publication medical journal
Language	English
Publication details
Publisher	Informa (Britain / USA)
Indexing
ISSN	1744-7623
Links
Journal homepage

Expert Opinion on Emerging Drugs is a MEDLINE-indexed, peer-reviewed, international journal publishing structured reviews on drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases.

Each review includes an ‘expert opinion’ section, in which authors are asked to provide their personal view on the current status and future direction of the research discussed.

Expert Opinion is published by Informa.

Expert Opinion on Emerging Drugs has an Impact Factor ^[1] of 3.284, and is available online or is published in paper format 4 times a year.

Contents

• Background
• Medical need
• Existing treatment
• Market review
• Current research goals
• Scientific rationale
• Competitive environment
• Potential development issues
• Conclusion
• Expert Opinion

Core Therapeutic Areas

• Pulmonary-allergy
• dermatological
• gastrointestinal
• arthritis
• Anti-infective
• Endocrine and metabolic
• Central and peripheral nervous systems
• Cardiovascular and renal
• Oncology

References